- Home
- ILAG vs CYCN Comparison
ILAG vs CYCN Comparison
Compare ILAG & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- CYCN
- Stock Information
- Founded
- ILAG 1981
- CYCN 2018
- Country
- ILAG Hong Kong
- CYCN United States
- Employees
- ILAG N/A
- CYCN N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- ILAG Consumer Discretionary
- CYCN Health Care
- Exchange
- ILAG Nasdaq
- CYCN Nasdaq
- Market Cap
- ILAG 9.4M
- CYCN 6.5M
- IPO Year
- ILAG 2022
- CYCN N/A
- Fundamental
- Price
- ILAG $0.51
- CYCN $3.62
- Analyst Decision
- ILAG
- CYCN
- Analyst Count
- ILAG 0
- CYCN 0
- Target Price
- ILAG N/A
- CYCN N/A
- AVG Volume (30 Days)
- ILAG 427.2K
- CYCN 30.1K
- Earning Date
- ILAG 07-22-2025
- CYCN 08-06-2025
- Dividend Yield
- ILAG N/A
- CYCN N/A
- EPS Growth
- ILAG N/A
- CYCN N/A
- EPS
- ILAG N/A
- CYCN N/A
- Revenue
- ILAG $7,506,551.00
- CYCN $2,081,000.00
- Revenue This Year
- ILAG N/A
- CYCN N/A
- Revenue Next Year
- ILAG N/A
- CYCN N/A
- P/E Ratio
- ILAG N/A
- CYCN N/A
- Revenue Growth
- ILAG 16.50
- CYCN N/A
- 52 Week Low
- ILAG $0.34
- CYCN $1.27
- 52 Week High
- ILAG $1.35
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- ILAG 51.90
- CYCN 63.94
- Support Level
- ILAG $0.49
- CYCN $2.95
- Resistance Level
- ILAG $0.52
- CYCN $3.73
- Average True Range (ATR)
- ILAG 0.05
- CYCN 0.33
- MACD
- ILAG -0.01
- CYCN 0.06
- Stochastic Oscillator
- ILAG 41.32
- CYCN 89.22
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.